Broken redirects

The following redirects link to non-existent pages:

Showing below up to 50 results in range #801 to #850.

801. Equine infectious anemia virus → Equine infectious anemia
802. Equipment Used in Percutaneous Coronary Intervention → Equipment used in percutaneous coronary intervention
803. Horsetails → Equisetum
804. Ergometrine → Ergonovine
805. Ergotrate Maleate → Ergonovine
806. Methylergonovine maleate → Ergonovine
807. Eric R. Kandel → Eric Kandel
808. Erich Huckel → Erich Hückel
809. EAGAR → Estrogen And Graft Atherosclerosis Research Trial
810. EASTER → Estrogen And Stents To Eliminate Restenosis
811. EPAT → Estrogen In The Prevention Of Atherosclerosis Trial
812. EMERAS → Estudio Multicentrico Estreptoquinasa Republicas De America Del Sur
813. EPAMSA → Estudio Piloto Argentino De Muerte Subita Y Amioda Rone (Argentine Pilot Study Of Sudden Death And Amiodarone)
814. ERACI → Estudio Randomizado Argentino De Angioplastia Vs. Cirugía (Argentine Randomized Trial Of Percutaneous Transluminal Coronary Angioplasty Versus Coronary Artery Bypass Surgery In Multivessel Disease)
815. ECLA GIK → Estudios Cardiologicos Latinoamerica Glucose-Insulin-Potassium Pilot Trial
816. Ethical → Ethics
817. ERGO → Etomoxir For The Recovery Of Glucose Oxidation
818. Eugenic → Eugenics
819. Euro-SPAH → European-Sonotherapy Prevention Of Arterial Hyperplasia
820. EARS → European Atherosclerosis Research Study
821. EAFT → European Atrial Fibrillation Trial
822. ECST → European Carotid Surgery Trial
823. EUROSTAR → European Cobalt Stent With Antiproliferative For Restenosis Trial
824. ECASS III → European Cooperative Acute Stroke Study III
825. ECSG-1 → European Cooperative Study Group For Recombinant Tissue-Type Plasminogen Activator
826. ECSG-6 → European Cooperative Study Group For Recombinant Tissue-Type Plasminogen Activator II
827. ECSS → European Coronary Surgery Study Group
828. ELUTES → European Evaluation Of Paclitaxel Eluting Stent
829. EMIT → European Mivazerol Trial
830. EMIAT → European Myocardial Infarction Amiodarone Trial
831. EMIP-FR → European Myocardial Infarction Project—Free Radicals
832. E-SIRIUS → European Sirolimus-Eluting Stent In Coronary Lesions
833. ESHRE → European Society of Human Reproduction and Embryology
834. EURO-SPAH → European Sonotherapy Trial To Prevent Arterial Hyperplasia
835. ESPS2 → European Stroke Prevention Study 2
836. ESPS-2 → European Stroke Prevention Study 2
837. ESTAT → European Stroke Treatment With Ancrod Trial
838. EUTOPIA → European Trial On Olmesartan And Pravastatin In Inflammation And Atherosclerosis
839. EUROPA → European Trial On Reduction Of Cardiac Events With Perindopril In Stable Coronary Artery Disease
840. ELECT → Evaluating Enoxaparin (Lovenox) Clotting Times
841. EPIC → Evaluation Of C7E3 For The Prevention Of Ischemic Complications
842. EDGE → Evaluation Of Daptomycin (Cidecin) In Gram-Positive Entities
843. EDGECAP → Evaluation Of Daptomycin (Cidecin) In Gram-Positive Entities In The Treatment Of Community-Acquired Pneumonia
844. EDGESST → Evaluation Of Daptomycin (Cidecin) In Gram-Positive Entities In The Treatment Of Complicated Skin And Soft Tissue Infections
845. EDGEUTI → Evaluation Of Daptomycin (Cidecin) In Gram-Positive Entities In The Treatment Of Complicated Urinary Tract Infection
846. A to Z, Phase Z → Evaluation Of Early Versus Delayed Initiation Of Simvastatin In Patients Who Receive Guideline Based Treatment For Acute Coronary Syndrome
847. ELITE → Evaluation Of Losartan In The Elderly
848. ENCORE I → Evaluation Of Nifedipine And Cerivastatin On Recovery Of Coronary Endothelial Function
849. EPISTENT → Evaluation Of Platelet IIb/IIia Inhibitor For Stenting Trial
850. EPILOG → Evaluation Of Ptca To Improve Long-Term Outcome By C7E3 Gp IIb/IIia Receptor (Abciximab) Blockade